SIPMeL Endocrinology and Metabolic Diseases Study Group (SG-EMD) edited the list of five practices at risk of inappropriateness issued in October 2016 and updated in 2018. All members of the SG assessed the timeliness of the recommendations starting at the 20 October 2023 meeting. A select group took charge of checking whether more current and relevant articles had been published between 2016 and 2023 and prepared a document to which the entire SG contributed. The final list of five updated recommendations was approved by all SG-EMD members, the president of SIPMeL and the steering group of Choosing Wisely Italy.